Patents Assigned to Auro Peptides Ltd
  • Patent number: 11572386
    Abstract: The present invention relates to a process for the preparation of Linaclotide by oxidizing linear Linaclotide of formula (II) using combination of air and oxidizing agent followed by purification using RP-HPLC.
    Type: Grant
    Filed: August 29, 2015
    Date of Patent: February 7, 2023
    Assignee: Auro Peptides Ltd.
    Inventors: Suresh Kumar Vadlamani, Patil Nilesh Dagadu, Shafee Mohammed Abdul, Sanjay Devidas Patil, Govindrajan Narayanan
  • Publication number: 20220235096
    Abstract: The present invention relates to a process for the preparation of Plecanatide, which comprises preparation of three fragments such as Fragment A (7 amino acids), Fragment B (3 amino acids), Fragment D (6 amino acids) and coupling the fragments to provide Plecanatide followed by purification using buffer system comprising Tris hydrochloride (or) Triethylammonium phosphate.
    Type: Application
    Filed: June 8, 2020
    Publication date: July 28, 2022
    Applicant: Auro Peptides Ltd
    Inventors: Abdul Shafee Mohammed, Damodar Reddy Pakal, Bharti Deshmukh, Vivekananda Reddy Goli, Nagana Goud Agasaladinni
  • Publication number: 20210317161
    Abstract: The present invention relates to a process for the preparation of Pasireotide of formula (I) and its acid addition salts. More particularly the present invention is directed to a process for the synthesis of Pasireotide of formula (I) having purity greater than 99.0% by HPLC using fragment coupling.
    Type: Application
    Filed: December 14, 2015
    Publication date: October 14, 2021
    Applicant: Auro Peptides Ltd
    Inventors: Nagana Goud Agasaladinni, Mohammed Abdul Shafee, Suresh Kumar Vadlamani, Patil Nilesh Dagadu, Mohan Rao Koppala
  • Patent number: 10344069
    Abstract: The present invention relates to a process for the preparation of Liraglutide, which comprises: a) synthesis of suitable fragments (protected) by solid phase peptide synthesis; b) coupling of the suitable fragments on solid support; c) concurrently cleaving the protected peptide from the solid support and de-protecting the peptide; d) purification of Liraglutide (crude) on reverse phase HPLC; e) isolating pure Liraglutide.
    Type: Grant
    Filed: October 31, 2015
    Date of Patent: July 9, 2019
    Assignee: Auro Peptides Ltd.
    Inventors: Suresh Kumar Vadlamani, Patil Nilesh Dagadu, Mohammed Abdul Shafee, Sanjay Devidas Patil, Nagana Goud Agasaladinni
  • Publication number: 20180251511
    Abstract: The present invention relates to a process for the preparation of Liraglutide, which comprises: a) synthesis of suitable fragments (protected) by solid phase peptide synthesis; b) coupling of the suitable fragments on solid support; c) concurrently cleaving the protected peptide from the solid support and de-protecting the peptide; d) purification of Liraglutide (crude) on reverse phase HPLC; e) isolating pure Liraglutide.
    Type: Application
    Filed: October 31, 2015
    Publication date: September 6, 2018
    Applicant: Auro Peptides Ltd
    Inventors: Suresh Kumar Vadlamani, Patil Nilesh Dagadu, Mohammed Abdul Shafee, Sanjay Devidas Patil, Nagana Goud Agasaladinni